Status report
Get it in writing
The official USPTO status record for XCELL PRP, serial 90780621, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
XCELL PRPSerial 90780621 · Principal Register
Live · Registered
Owner: APEX BIOLOGIX, INC.
Class 010 -
Filed Jun 17, 2021
Registered Jun 07, 2022
The record shows that “XCELL PRP” is a live, registered mark on the Principal Register owned by APEX BIOLOGIX, INC. The goods listed are a wide range of blood‑analysis and blood‑collection apparatus, including blood‑drawing devices, blood‑tubing sets, filters, and related medical devices for processing human platelets and other blood components. A similar name would raise the closest concern in the medical device and blood‑collection field, especially where the products or services involve blood sampling or stem‑cell regeneration. This record does not give the owner control over every use of the word “PRP” or “XCELL” outside that specific medical context. The prosecution history shows a smooth path to registration with no opposition or enforcement actions recorded. The most recent event is the registration confirmation on June 7, 2022. No enforcement activity appears in the supplied history. If you plan to use a similar name in medical device or blood‑collection services, this mark represents a meaningful risk.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.